VIENNA -- For patients in the early stages of pulmonary arterial hypertension, the use of bosentan (Tracleer) appears to slow the progressive worsening of symptoms.

VIENNA -- Once again a major clinical trial using vitamins to lower homocysteine levels has failed to change clinical outcomes for patients with heart disease.

SEOUL, South Korea -- Pemetrexed (Alimta) may have toxicity advantages over gemcitabine (Gemzar) in first-line combination chemotherapy for advanced non-small cell lung cancer, researchers said here.

DENVER -- A microwave-popcorn addict who found the aroma of the freshly made snack to be irresistibly intoxicating has developed brochiolitis obliterans, suggested a pulmonologist here.

VIENNA -- In the 12 months following implementation of a nationwide smoking ban in Ireland, the number of hospital admissions for acute coronary syndrome decreased by 11%.

VIENNA -- Unlike the benefits found in men for early invasive treatment of non-ST elevation acute coronary syndrome, this strategy may increase the risk of excess bleeding or death in women, researchers here reported.

SEOUL, South Korea -- Hand-rolled cigarette smokers appear to be at higher risk of lung cancer than those who smoke commercially manufactured brands, researchers found.

LEBANON, N.H. -- Teens who see more smoking in movies may be more likely to get hooked themselves.

MONTREAL -- Doctors who scored poorly on the patient-physician communications and clinical decision-making portions of a clinical skills exam were significantly more likely to be the targets of patient complaints to medical authorities than fair or good communicators.

SEOUL, South Korea -- Lung cancer patients with bone metastases may live longer when treated with bisphosphonates, a study reported here suggests.

SEOUL -- Some patients with malignant mesothelioma may have a prognosis that's not quite so grim as widely believed, a Nordic collaborative group reported here.

SEOUL, South Korea -- While, overall, women with advanced stage lung cancer tend to live longer than men, the same is not true for premenopausal women, researchers found.

VIENNA -- Time and more patients shrank the 18% three-year statistically significant risk of mortality for drug-eluting coronary stents, compared with bare-metal devices, to a non-significant 1% at four years, Swedish registry researchers reported here today.

The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention was held in Sydney, Australia, July 22 to 25, 2007

Two years ago, while revisiting the quality and durability of highly active antiretroviral therapy-linked immune reconstitution, I noted that the incidence of certain non-AIDS-defining malignancies associated with sexually transmitted viruses in immunosuppressed persons, including penile, oral, and anal cancers, have continued to increase among HIV-infected persons despite the use of highly active antiretroviral therapy

A previously healthy 43-year-old man was referred to the hospital for the diagnosis of a nodular lesion in the mandibular gingiva.

Oral cavity lymphoma occurs frequently in HIV-positive patients, often with a poor prognosis.1 Ortega and colleagues2 present an enlightening case of a destructive oral plasmablastic lymphoma in a 43-year-old HIV-positive man. Similar to another recently reported case,3 this lymphoma was their patient's first manifestation of his underlying HIV infection.

Thinking about the potential use of a vaccine to control or eliminate the spread of HIV has been present since the earliest days of the epidemic.

Tens of thousands of persons with HIV/AIDS have seen their treatment interrupted by the worldwide recall of Roche Pharmaceuticals’ protease inhibitor Viracept (nelfinavir).

We conducted a survey of 154 inmates of the Rhode Island Department of Corrections jail regarding HIV risk, HIV testing experiences, and attitudes toward rapid HIV testing in the correctional setting.